Knockdown of VPS26A suppressed the growth, migration and invasion abilities of pancreatic cancer cell lines while overexpression of VPS26A enhanced those in vitro through regulating the EGFR/ERK signaling pathway. This evidence concerns the gene VPS26A and pancreatic neoplasm.